PortfoliosLab logo
Tools
Performance Analysis
Risk Analysis
Optimization
Factor Model
See All Tools
Portfolio Analysis
Portfolios
Lazy PortfoliosUser Portfolios
Discussions

AnaptysBio, Inc. (ANAB)

Equity · Currency in USD · Last updated Nov 25, 2023
SummaryFinancials

Company Info

ISINUS0327241065
CUSIP032724106
SectorHealthcare
IndustryBiotechnology

Highlights

Market Cap$377.37M
EPS-$5.42
Revenue (TTM)$14.96M
Gross Profit (TTM)-$78.51M
EBITDA (TTM)-$150.78M
Year Range$13.56 - $32.44
Target Price$26.25
Short %27.97%
Short Ratio24.34

Share Price Chart


Loading data...

Performance

The chart shows the growth of an initial investment of $10,000 in AnaptysBio, Inc., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


-20.00%-10.00%0.00%10.00%JuneJulyAugustSeptemberOctoberNovember
-23.38%
8.42%
ANAB (AnaptysBio, Inc.)
Benchmark (^GSPC)

S&P 500

Compare to other instruments

Search for stocks, ETFs, and funds to compare with ANAB

AnaptysBio, Inc.

Popular comparisons: ANAB vs. VOO

Return

AnaptysBio, Inc. had a return of -53.89% year-to-date (YTD) and -48.87% in the last 12 months.


PeriodReturnBenchmark
Year-To-Date-53.89%18.75%
1 month-18.90%8.90%
6 months-23.38%8.42%
1 year-48.87%13.21%
5 years (annualized)-28.06%11.63%
10 years (annualized)N/A9.74%

Monthly Returns Heatmap


JanFebMarAprMayJunJulAugSepOctNovDec
2023-4.32%-8.26%6.49%-3.10%-0.15%-8.74%-9.19%

Risk-Adjusted Performance

This table presents a comparison of risk-adjusted performance metrics for AnaptysBio, Inc. (ANAB) and S&P 500 (^GSPC). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratioSortino ratioOmega ratioCalmar ratioUlcer Index
ANAB
AnaptysBio, Inc.
-0.92
^GSPC
S&P 500
0.98

Sharpe Ratio

The current AnaptysBio, Inc. Sharpe ratio is -0.92. A negative Sharpe ratio means that the risk-free rate is higher than the portfolio's return. This value does not convey any meaningful information.


Rolling 12-month Sharpe Ratio-1.00-0.500.000.501.00JuneJulyAugustSeptemberOctoberNovember
-0.92
0.98
ANAB (AnaptysBio, Inc.)
Benchmark (^GSPC)

Dividend History


AnaptysBio, Inc. doesn't pay dividends

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


-80.00%-60.00%-40.00%-20.00%0.00%JuneJulyAugustSeptemberOctoberNovember
-88.88%
-4.95%
ANAB (AnaptysBio, Inc.)
Benchmark (^GSPC)

Worst Drawdowns

The table below displays the maximum drawdowns of the AnaptysBio, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the AnaptysBio, Inc. was 92.08%, occurring on Nov 8, 2019. The portfolio has not yet recovered.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-92.08%Mar 5, 2018426Nov 8, 2019
-32.97%Mar 31, 201747Jun 7, 201732Jul 24, 201779
-32.31%Jul 25, 201716Aug 15, 201715Sep 6, 201731
-14.04%Jan 25, 20188Feb 5, 20187Feb 14, 201815
-10.4%Oct 13, 20174Oct 18, 201718Nov 13, 201722

Volatility Chart

The current AnaptysBio, Inc. volatility is 17.42%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


5.00%10.00%15.00%20.00%JuneJulyAugustSeptemberOctoberNovember
17.42%
3.39%
ANAB (AnaptysBio, Inc.)
Benchmark (^GSPC)

Recent discussions